Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Hemato Oncology Testing
... by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Hemato Oncology Testing Services, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$8.6 ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Gynecological Cancer Drugs
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Cervical Cancer Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$10.3 Billion ... Read More
-
Interventional Oncology Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Oncology Information Systems
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by ... Read More
-
Immunotherapy Drugs
... at a CAGR of 9.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of ... Read More
-
Breakthrough Therapy (BT) Designation
... reach US$415.7 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach ... Read More
-
Global Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Type (Pemetrexed and Combination, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Other Drug Types), By Route of Administration, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “Global Malignant Pleural Mesothelioma Market (2024 Edition)” which provides a Pemetrexed and Combination analysis of the Global Malignant Pleural Mesothelioma industry in terms ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Non-Melanoma Skin Cancer
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 ... Read More
-
NDDS in Cancer Therapy
... reach US$73.2 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2023-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$67.8 ... Read More
-
Immuno-Oncology
... of 16.2% over the analysis period 2023-2030. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$75.1 Billion by the end of the analysis ... Read More
-
Cancer Immunotherapy
... at a CAGR of 13.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$266.2 Billion by the end of ... Read More
-
Cancer Biomarkers
... at a CAGR of 16.8% over the analysis period 2023-2030. Protein Biomarkers, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$42.9 Billion by the end of ... Read More
-
Cancer Registry Software
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Standalone Software, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$116.6 Million by ... Read More
-
Head and Neck Cancer Therapeutics
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Cervical Cancer Treatment
... at a CAGR of 5.9% over the analysis period 2023-2030. Squamous Cell Carcinoma (SCC) Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$9.1 Billion by ... Read More
-
Global Lung Cancer Therapy Market: Analysis By Treatment Method (Non-Invasive and Minimally Invasive), By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies), By Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 ... Read More
-
Clinical Trials Market Analysis and Forecast to 2033: By Phase (Phase I, Phase Ii, Phase Iii, Phase Iv, Preclinical), Design (Interventional Trials, Observational Trials, Expanded Access Trials), Indication (Oncology, Cardiology, Neurology, Infectious Diseases, Gastroenterology, Immunology, Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic Institutions, Medical Device Manufacturers, Public Health Organizations), and Region
... Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic ... Read More
-
Global Therapeutic Cancer Vaccines Market Growth 2024-2030
... the Therapeutic Cancer Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Therapeutic Cancer ... Read More
-
Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global cancer diagnostics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global cancer ... Read More
-
Artificial Intelligence (AI) in Oncology Market - Forecasts from 2024 to 2029
... size of US$8.944 billion by 2029, up from US$1.963 billion in 2024. The oncology discipline has seen tremendous breakthroughs with the help of artificial intelligence (AI). Multiple advantages offered by AI are driving its increased ... Read More
-
Nuclear Medicine Equipment Market Size, Share & Trends Analysis Report By Type (SPECT, PET, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, General Imaging), By End Use, By Region, And Segment Forecasts, 2024 - 2030
... Nuclear Medicine Equipment Market Growth & Trends The global nuclear medicine equipment market size is expected to reach a value of USD 8.47 billion by 2030 and is projected to grow at a CAGR of ... Read More
-
Cancer/Tumor Profiling Market Size and Forecasts (2020 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology (Next-Generation Sequencing, PCR, Immunohistochemistry, In Situ Hybridization); Application (Diagnostics, Biomarker Discovery, Personalized Medicine); and End-User (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies)
... (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies) Cancer/Tumor Profiling Market Size Estimation: As of 2020, the global cancer/tumor profiling market was valued at approximately USD 12.50 billion. It is projected to reach around ... Read More
Research Assistance
